Black Patients With Early-Stage Colon Cancer Get Worse Care Than Whites: Study
By Ernie Mundell HealthDay Reporter
FRIDAY, Nov. 10, 2023 (HealthDay) -- Rates of colon cancer among relatively young Americans continue to rise, and a new study suggests that a patient's race might determine the quality of cancer care they receive.
Being a Black patient appeared linked to lower odds of receiving "guideline-concordant" care for colon and rectal cancers, compared to white patients, according to a study published Nov. 8 in the Journal of Clinical Oncology.
“Colorectal cancer is a leading cause of cancer death in the U.S., and the incidence and mortality rates among young adults are rising,” noted study lead author Leticia Nogueira.
“Research also shows young Black individuals are more likely to die after a colorectal cancer diagnosis than White individuals," said Nogueira, who is scientific director of health services research at the American Cancer Society (ACS). "This is why addressing racial disparities is so important, to ensure everyone receives needed, timely treatment to help battle this disease.”
In the study, she and her colleagues tracked the care of almost 85,000 colon cancer patients and nearly 63,000 rectal cancer patients, all aged between 18 and 49 at the time they were diagnosed.
To be deemed to have received care in line with expert guidelines, patients were expected to have received proper staging of their disease, lymph node testing and recommended chemotherapy and/or radiotherapy.
Black patients were more likely to have gone without recommended care than white patients, the study concluded.
Parsing out why that might be so, Noguiera's team found that about 28% of the disparity for colon cancer patients could be blamed on a relative lack of health insurance among Black patients.
Longer wait times among Black patients to receive recommended therapies also played a role.
“With health insurance being the largest modifiable factor contributing to racial disparities in this study, it’s critical to eliminate this barrier,” Nogueira said in an ACS news release. “Expanding access to health insurance coverage could help improve colorectal care and outcomes."
Sources
- American Cancer Society, news release, Nov. 8, 2023
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Survey Shows Men Need to Do More to Prevent Cancer
FRIDAY, July 5, 2024 -- American men are blowing their best chance to head off cancer or spot it early, when it's easiest to treat, a new survey warns. More than 6 in 10 (65%)...
Mediterranean Diet Ups Survival Odds After Cancer
WEDNESDAY, July 3, 2024 -- The Mediterranean diet can help cancer survivors maintain their heart health and live longer, a new study says. Cancer patients whose eating patterns...
Exercise May Prevent the Nerve Damage That Comes With Chemotherapy
TUESDAY, July 2, 2024 -- Simple exercises performed during rounds of chemotherapy can help people avoid nerve damage normally associated with the cancer-killing drugs, a new study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.